Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Lucas, Adriana
DOB: 22-OCT-1977 (Age: 48)
Gender: female
ID: 5083-440869-7 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 19-JUN-2025

Problem list

Condition Onset Date Status
Polyp of colon 16-Jan-2025 active
Sepsis 30-Aug-2023 active
Ischemic heart disease 08-Jun-2023 active
Metabolic syndrome X 14-Dec-2017 active
Prediabetes 05-Apr-2012 active
Essential hypertension 05-Apr-2012 active
Dependent drug abuse 26-Apr-1991 active
Impacted molars 10-Aug-1990 active
Chronic intractable migraine without aura 03-Feb-1990 active

Medication list

No known medications

Immunizations list

Vaccine Date
Live attenuated Human alphaherpesvirus 3 only vaccine product 19-Jun-2025
Influenza virus antigen only vaccine product 19-Jun-2025
SARS-CoV-2 mRNA vaccine 13-May-2021
Hepatitis A virus antigen only vaccine product 28-Apr-2016
Clostridium tetani toxoid antigen adsorbed only vaccine product 28-Apr-2016

Procedure History list

Procedure Date Reason
Postoperative procedure education 14-Sep-2023 History of coronary artery bypass grafting (situation)
Stair-climbing test 14-Sep-2023 History of coronary artery bypass grafting (situation)
Walking exercise test 14-Sep-2023 History of coronary artery bypass grafting (situation)
Discharge to ward 14-Sep-2023 -
Discharge from hospital 14-Sep-2023 History of coronary artery bypass grafting (situation)
Electrocardiographic procedure 13-Sep-2023 -
Transfusion of packed red blood cells 13-Sep-2023 -
Plain X-ray of chest 13-Sep-2023 -
Transfusion of fresh frozen plasma 12-Sep-2023 -
Removal of endotracheal tube 12-Sep-2023 -
Resuscitation using intravenous fluid 30-Aug-2023 Sepsis (disorder)
Transfer to stepdown unit 30-Aug-2023 Sepsis (disorder)
Medication reconciliation 07-Dec-2017 -
Depression screening 30-Nov-2017 -
Assessment of health and social care needs 30-Nov-2017 -
Screening for domestic abuse 30-Nov-2017 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 30-Nov-2017 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Lifestyle education regarding hypertension 05-Apr-2012 Essential hypertension (disorder)
  • Maintain blood pressure below 130/80 mmHg through lifestyle modifications.
  • Achieve a 5% reduction in body weight to improve blood pressure control.
  • Engage in at least 150 minutes of moderate-intensity aerobic physical activity per week.
  • Limit sodium intake to less than 2.3 grams per day to support blood pressure control.
Diabetes self management plan 05-Apr-2012 Prediabetes
  • Achieve and maintain Hemoglobin A1c below 5.7% to reduce risk of progression from prediabetes to diabetes.
  • Achieve and maintain a healthy body weight to support glycemic control and reduce cardiometabolic risk.
  • Maintain blood pressure below 130/80 mmHg to reduce cardiovascular risk associated with prediabetes.
  • Engage in at least 150 minutes of moderate-intensity physical activity per week to improve insulin sensitivity and metabolic health.
Care plan 07-Oct-1993 -

Vital Signs

Vital Signs 2025-06-19 2024-06-13
Body Height 164 cm 164 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} 3 {score}
Body Weight 83.3 kg 81.7 kg
Body mass index (BMI) [Ratio] 31 kg/m2 30.4 kg/m2
Diastolic Blood Pressure 74 mm[Hg] 68 mm[Hg]
Systolic Blood Pressure 111 mm[Hg] 111 mm[Hg]
Heart rate 90 /min 66 /min
Respiratory rate 13 /min 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 19-JUN-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 97.2 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.2 7 - 45 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.9 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 139.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.6 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 105.2 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 20.5 L 22 - 29 mmol/L

Device Use

Device Date (since)
Blood glucose meter (physical object) 05-Apr-2012